Lisa Moneymaker

Medidata Solutions, a Dassault Systèmes company

VP, Producer Management, RBM

Lisa is the Vice President of Product for Risk Based Monitoring capabilities for Medidata Solutions. She has nearly 20 years of pharma, biotech, and medical device industry experience, delivering complex system solutions in support of excellence in clinical trial execution. Lisa has spent time both in consulting and in Information System leadership for Amgen, directing architecture and development of the Clinical Trial Management ecosystem. While at Amgen, Lisa was also allocated to leadership roles within TransCelerate Biopharma, driving industry innovation through delivery of the Shared Investigator Platform and the Investigator Registry.

All Sessions by Lisa Moneymaker

  • October 8

    Thursday EDT

  • 4:30 PM  - 5:30 PM
    With the COVID-19 pandemic, the impact on clinical trials is unmistakable. Digital innovations that might have once taken months or years to be adopted have been integrated into practice in days or weeks. Digital operating models - such as telemedicine, remote monitoring, and synthetic controls that have been discussed and piloted endlessly are now enabling clinical trials to move forward. Even when the COVID-19 outbreak is contained, it’s unlikely these digital transformations will go away. This session will explore how sites, sponsors, and CROs are embracing new technologies and digital operating models while positioning themselves for success in the long term.
    Plenary




Share

Lisa Moneymaker
REGISTER NOW
css.php